Hematology/Oncology

Tabbara N, Sharp J, Gaut D, Pham TTD, Tang K, Oliai C, Sim MS, Schiller G, Young P, Sasine JP. Diminished durability of chimeric antigen[...]

By rosaguerrero • June 16, 2022

Khan SU, Yedlapati SH, Lone AN, Khan MS, Wenger NK, Watson KE, Gulati M, Hays AG, Michos ED. A comparative analysis of premature heart disease-[...]

By rosaguerrero • May 23, 2022

Chlebowski RT, Manson JE. Menopausal Hormone Therapy and Breast Cancer. Cancer J. 2022 May-Jun 01;28(3):169-175. doi: 10.1097/PPO.0000000000000601. PMID: 35594463.

By rosaguerrero • May 21, 2022

Baxter-King R, Brown JR, Enos RD, Naeim A, Vavreck L. How local partisan context conditions prosocial behaviors: Mask wearing during COVID-19. Proc Natl Acad Sci[...]

By rosaguerrero • May 18, 2022

Schadendorf D, Dummer R, Robert C, Ribas A, Sullivan RJ, Panella T, McKean M, Santos ES, Brill K, Polli A, Pietro AD, Ascierto PA. STARBOARD:[...]

By rosaguerrero • May 6, 2022

Li S, Zeng W, Ni X, Zhou Y, Stackpole ML, Noor ZS, Yuan Z, Neal A, Memarzadeh S, Garon EB, Dubinett SM, Li W, Zhou[...]

By rosaguerrero • May 2, 2022

Brief Summary The purpose of this study is to evaluate pembrolizumab (MK-3475) subcutaneous (SC) administration as the first-line therapy in the treatment of metastatic squamous[...]

By • April 21, 2022

D'Ambruoso SF, Glaspy JA, Hurvitz SA, Wenger NS, Pietras C, Ahmed K, Drakaki A, Goldman JW, Anand S, Simon W, Kung J, Coscarelli A, Rosen[...]

By sjmartinez • April 18, 2022